Skip to content

Author

Somdatta Y Chaudhari

We have 5 of 30 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Synthesis, In-Vitro, and In-silico analysis of Repurposed Substituted 2,7-Dimethylimidazo [1,2-a]Pyridine-3-Carboxamide based α-Amylase inhibitors via docking, MMGBSA, dynamics simulation techniques and pharmacokinetic evaluation

In-silico ADME studies indicated favorable pharmacokinetic properties, including high gastrointestinal absorption, low TPSA, BBB permeability, and compliance with Lipinskis rule, while toxicity prediction suggested acceptable safety profiles for the synthesized derivatives, highlighting their potential as promising α-a...

Suraj N. Mali, Prachi Singh, Somdatta Y. Chaudhari et al. · 0 citations
Sep 2026

Atom-based 3D-QSAR, pharmacophore modelling and molecular dynamics guided identification of thienopyrimidinone derivatives targeting EGFR in breast cancer.

Breast cancer still ranks to be one of the primary causes of cancer-related death worldwide, underscoring the critical need for innovative targeted treatment agents with enhanced safety and efficacy. The current work examined Thienopyrimidinone-based derivatives as possible EGFR inhibitors for breast cancer treatment u...

Shashikant V. Bhandari, Rutuja R. Napte, S. Patil et al. · 0 citations
Aug 2026

A highly efficient one-pot approach for the synthesis of novel 5-amino-4-Cyano-Pyrazoles with promising anti-inflammatory and broad-spectrum antimicrobial activity.

Computer studies provided further support for the observed COX-2 inhibition and indicated favorable pharmacokinetic profiles of the synthesized 5-Amino-4-cyanopyrazole derivatives, highlighting the synthetic efficiency of the developed one-pot protocol and the promising biological potential of the synthesized derivativ...

M. Kokane, Dnyandev Bhosale, Dattatraya G. Raut et al. · 0 citations
Aug 2026

Computational and Experimental Approaches for HPMCAS-Based Solid Dispersions of Abiraterone Acetate: Formulation, Characterization, and Biopharmaceutical Enhancement Evaluation.

The solid dispersion of ABA with HPMCAS-LF significantly improved solubility, dissolution, and diffusion, highlighting its potential for enhanced oral bioavailability and improved therapeutic outcomes.

Namrata S. Desai, A. Shete, Snehal S. Patil et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.